Amgen's Leukemia Rx is Effective & Expensive
Earlier this month, the US Food and Drug Administration (FDA) approved a new type of treatment for a severe form of leukemia. That treatment becomes available Thursday, and the manufacturer has revealed how much it will cost.
Quality of Life May Raise Quantity of Life With Lymphoma
Feeling good about life may make it last a little longer. Lymphoma patients with high quality of life may live longer than those with lower life satisfaction.
FDA Approves First Test for Group of Human Retroviruses
The U.S. Food and Drug Administration today approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II).
Rx Combo Slowed Multiple Myeloma
When it comes to treating multiple myeloma, three medications may be better than two.
Eric Berry Diagnosed With Hodgkin Lymphoma
Kansas City Chiefs safety Eric Berry has been diagnosed with Hodgkin lymphoma. Fortunately, his medical team has an optimistic outlook.
FDA Approves Rx for Bone Marrow Disease
The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
Patients Have Power to Lower Post-Surgery Clot Risk
The risk for blood clots may go up after surgery, but patients can take steps to lower that risk.
FDA Approves Blincyto to Treat Rare Form of Leukemia
The U.S. Food and Drug Administration today approved Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL), an uncommon form of ALL.
Immune Diseases Were More Common in Those Born by C-Section
Could the birth process have a role in immune disease development? A common birthing method may raise babies' risk of immune diseases later, a new study found.
FDA Approves Rx for Rare Type of Hemophilia
The US Food and Drug Administration (FDA) approved a new treatment Thursday for a rare form of hemophilia.